ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 1 filers reported holding ACCELERON PHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $16,247,000 | +135291.7% | 94,406 | +101411.8% | 0.02% | – |
| Q4 2020 | $12,000 | -99.9% | 93 | -100.0% | 0.00% | -100.0% |
| Q4 2016 | $9,453,000 | -30.5% | 370,424 | +3.6% | 0.02% | -39.5% |
| Q1 2015 | $13,603,000 | -8.6% | 357,413 | -6.4% | 0.04% | -7.3% |
| Q4 2014 | $14,875,000 | +22.6% | 381,805 | -4.8% | 0.04% | +13.9% |
| Q3 2014 | $12,131,000 | -13.3% | 401,170 | -2.6% | 0.04% | -10.0% |
| Q2 2014 | $13,988,000 | +40.6% | 411,781 | +42.8% | 0.04% | +42.9% |
| Q1 2014 | $9,949,000 | – | 288,374 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,449,300 | $59,537,000,000 | 6.61% |
| Foresite Capital Management II, LLC | 188,602 | $7,748,000 | 4.36% |
| Foresite Capital Management III, LLC | 254,923 | $10,472,000 | 3.43% |
| Artal Group S.A. | 1,500,000 | $61,620,000 | 2.49% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,305,174 | $53,617,000 | 1.93% |
| Asymmetry Capital Management, L.P. | 82,473 | $3,388,000 | 1.84% |
| QVT Financial LP | 190,977 | $7,845,000 | 1.66% |
| SECTORAL ASSET MANAGEMENT INC | 269,396 | $11,067,000 | 1.32% |
| Sofinnova Investments, Inc. | 241,043 | $9,902,000 | 0.91% |
| Novo Holdings A/S | 119,708 | $4,918,000 | 0.69% |